PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Pfaar, O.* ; Agache, I.* ; de Blay, F.* ; Bonini, S.* ; Chaker, A.M.* ; Durham, S.R.* ; Gawlik, R.* ; Hellings, P.W.* ; Jutel, M.* ; Kleine-Tebbe, J.* ; Klimek, L.* ; Kopp, M.V.* ; Nandy, A.* ; Rabin, R.L.* ; van Ree, R.* ; Renz, H.* ; Roberts, G.* ; Salapatek, A.M.* ; Schmidt-Weber, C.B. ; Shamji, M.H.* ; Sturm, G.J.* ; Virchow, J.C.* ; Wahn, U.* ; Willers, C.* ; Zieglmayer, P.* ; Akdis, C.A.*

Perspectives in allergen immunotherapy: 2019 and beyond.

Allergy 74, 3-25 (2019)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
The seventh "Future of the Allergists and Specific Immunotherapy (FASIT)" workshop held in 2019 provided a platform for global experts from academia, allergy clinics, regulatory authorities and industry to review current developments in the field of allergen immunotherapy (AIT). Key domains of the meeting included the following: (a) Biomarkers for AIT and allergic asthma; (b) visions for the future of AIT; (c) progress and data for AIT in asthma and the updates of GINA and EAACI Asthma Guidelines (separated for house dust mite SCIT, SLIT tablets and SLIT drops; patient populations) including a review of clinically relevant endpoints in AIT studies in asthma; (d) regulatory prerequisites such as the "Therapy Allergen Ordinance" in Germany; (e) optimization of trial design in AIT clinical research; (f) challenges planning and conducting phase III (field) studies and the future role of Allergen Exposure Chambers (AEC) in AIT product development from the regulatory point of view. We report a summary of panel discussions of all six domains and highlight unmet needs and possible solutions for the future.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
6.771
1.931
50
54
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Allergen Exposure Chamber ; Allergen Immunotherapy ; Allergic Asthma ; Biomarker ; Clinical Trials; Grass-pollen Immunotherapy; Eaaci Ait Guidelines; Sublingual Immunotherapy; Double-blind; Subcutaneous Immunotherapy; Clinical-efficacy; Treatment Phase; Venom Allergy; Food Allergy; Asthma
Sprache
Veröffentlichungsjahr 2019
HGF-Berichtsjahr 2019
ISSN (print) / ISBN 0105-4538
e-ISSN 1398-9995
Zeitschrift Allergy
Quellenangaben Band: 74, Heft: S108, Seiten: 3-25 Artikelnummer: , Supplement: ,
Verlag Wiley
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Allergy Research (IAF)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Allergy
PSP-Element(e) G-505400-001
DOI 10.1111/all.14077
WOS ID WOS:000505281100001
Scopus ID 85077081957
PubMed ID 31872476
Erfassungsdatum 2020-01-28
[➜Korrektur melden]